Incorporating Preimplantation Genetic Testing into Today’s Fertility Practice | Illumina Video

27 February 2015

Dr. Kaylen Silverberg discusses the latest advancements in preimplantation screening (PGS) and summarizes several key IVF studies. He highlights the advantages of incorporating PGS into today’s fertility practice, including enhanced embryo selection, higher pregnancy rates, and lower miscarriage rates. Video Presenter Dr. Kaylen Silverberg Clinical Assistant Professor Department of Obstetrics & Gynecology Division of Reproductive Endocrinology & Infertility University of Texas Southwestern Medical School at Austin Related link http://www.illumina.com/clinical/reproductive-genetic-health.html

Share this article on    
    
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.